Delving into the Latest Updates on SB-P8B2 with Synapse

Overview

Basic Info

Drug Type

Small molecule drug

Synonyms

SB P8B2, SBP8B2

Target

FtsZ

Action

inhibitors

Mechanism

FtsZ inhibitors(bacterial FtsZ inhibitors)

Therapeutic Areas

Infectious Diseases

Active Indication-

Inactive Indication

Tuberculosis

Originator Organization

Stony Brook University

Active Organization-

Inactive Organization

Stony Brook University

Drug Highest PhasePendingPreclinical

First Approval Date-

Regulation-

Structure/Sequence

Molecular FormulaC22H32N4O2

InChIKeyMMGPENLTZQKVBO-UHFFFAOYSA-N

CAS Registry1259926-60-7

Fascioliasis is an infectious parasitic disease distributed globally and caused by the liver fluke Fasciola hepatica or F. gigantica . This neglected tropical disease affects both animals and humans, and it represents a latent public health problem due to the significant economic losses related to its effects on animal husbandry.

01 Sep 2018·Antimicrobial agents and chemotherapyQ2 · MEDICINE

Screening of Preselected Libraries Targeting Mycobacterium abscessus for Drug Discovery

Q2 · MEDICINE

Article

Author: Av-Gay, Yossef ; Chao, Joseph ; Ko, Mary ; Strauch, Angelika ; Richter, Adrian

Mycobacterium abscessus is intrinsically resistant to many antimycobacterial antibiotics, which presents serious problems in therapy. Here, we describe the development of a novel phenotype-based microscopic and computerized imaging drug screening approach.

100 Deals associated with SB-P8B2

Login to view more data